The first patient trial of the device, which needs to be optimised before clinical application, shows its ability to identify a biomarker of this type of cancer in blood plasma using a low-cost, easy-to-use test strip. The prototype can distinguish the presence of the sAXL biomarker between samples from patients with pancreatic cancer and healthy individuals, indicating its potential application at the point of patient care.
29/05/2026 - Events
A study published in Archivos de Bronconeumologia highlights that three out of four people selected to participate in a lung cancer screening programme because they were at high risk of developing the disease want to quit smoking, but almost 80% rule out quitting if the test result is negative. This shows that the intention to give up the habit does not mean being prepared to do so. They also have a low perception of their risk of developing lung cancer, and 40% do not agree with being considered people at risk of this disease. The work highlights the importance of combining smoking cessation programmes with population screening, so that screening can reach its full potential to reduce lung cancer mortality.
Més informació "Chronic smokers are not prepared to quit smoking"
28/05/2026 - General information
Two studies by the Bronchiectasis Unit at Hospital del Mar point to new ways to address sarcopenia, the progressive loss of muscle mass, in patients diagnosed with bronchiectasis. The studies are published in the journal ERJ Open Research, published by the European Respiratory Society. The Bronchiectasis Unit of the Pulmonology Department at Hospital del Mar has just published two studies in the journal ERJ Open Research that may pave the way for applying new treatments focused on sarcopenia in people diagnosed with bronchiectasis. Their significance lies in the fact that people diagnosed with bronchiectasis show loss of muscle mass early on and in mild and moderate stages of this respiratory disease. This is why it is so important to understand the molecular mechanisms involved.
Més informació "Opening the door to new therapeutic strategies in patients with bronchiectasis"
21/05/2026 - Institutional news
The grants will support three research projects in the field of sarcopenia in people with chronic respiratory diseases, the application of phage therapy in lung disease caused by non-tuberculous mycobacteria, and lung cancer screening. The grants will be presented on 6 June during SEPAR's 59th congress. The scientific committee for the SEPAR 2026 grants call has awarded three grants to projects led by professionals from the Hospital del Mar Pneumology Department and researchers from the Hospital del Mar Research Institute (HMRIB). Overall, this grant call from the Sociedad Española de Neurmología y Cirugía Torácica has distributed more than 600,000 euros to promote research.
An international study involving researchers from the Hospital del Mar Research Institute reveals a key interaction between two proteins that are fundamental in tumour development. To achieve this, molecular modelling and artificial intelligence techniques were used, revealing for the first time a new structural model that describes a previously unknown cell-signalling mechanism. The research opens the door to designing drugs that act on the interaction between the two proteins, thereby improving current cancer treatments.
Més informació "A new pathway for developing cancer drugs discovered"
18/05/2026 - Covid-19
An international study published in the journal Nature has designated a subset of the so-called dark proteins - proteins with no known function - as peptideins. Characterising them opens the door to studying them and analysing their functions. The TransCODE consortium, of which the Hospital del Mar Research Institute is the only research centre in Spain to be a member, has just published a new article that advances knowledge of the so-called dark genome, a part of the human genome that has not been studied and whose function is unknown. The journal Nature publishes the study, in which it designates thousands of previously unannotated proteins as peptideins.
13/05/2026 - General information
The ENDURE project aims to explore whether ultra-endurance athletes can serve as a model for this type of disease. The study received the Grant from the Foundation of the Catalan Society of Neurology during the Society's 30th meeting, held on 7 and 8 May in Barcelona. The project "Molecular basis of the relationship between ultra-endurance exercise and amyotrophic lateral sclerosis: a proteomic approach" - the ENDURE Project - has received the Grant from the Foundation of the Catalan Society of Neurology. Presented by Dr Paula Encina Garcia, a resident in the Neurology Department at Hospital del Mar, the study was recognised at the Society's 30th annual meeting.
12/05/2026 - Press release
In an article published in the journal Neuron, Dr. Rodrigo Quian Quiroga proposes that the way we organize our memories constitutes the mechanism that gives rise to human intelligence. The human brain generates memories from the representation of the stimuli it receives, endowing them with meaning. This is a mechanism of abstraction that does not merely store information. Published scientific evidence indicates that this mechanism is not found in other animal species, suggesting that it is a key element in the construction of our intelligence.
Més informació "The way we remember is the basis of human intelligence"
11/05/2026 - Events
On 5 May, the Hospital del Mar Research Institute Barcelona hosted the 5th edition of Biocat Tech Transfer Day, Biocat's flagship annual event on technology transfer, which this year was held in collaboration with the institute. The event brought together around 150 professionals and provided an excellent opportunity to share knowledge and strengthen ties with other key stakeholders in the health innovation ecosystem.
08/05/2026 - Press release
An international collaborative study, published in the Journal of Experimental Medicine, highlights the role of immunoglobulin D (IgD) in the processes involved in generating tolerance to antigens and bacteria that live in our body. The study characterizes, for the first time, the cells that produce these antibodies and identifies their point of origin in the tonsils. These results open the door to the possibility of developing drugs and vaccines focused on this type of antibody, both for the treatment of allergies and other diseases linked to inflammation
Més informació "Researchers identify one of the mechanisms that may regulate allergen tolerance"
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
